Welcome to our dedicated page for Health In Tech news (Ticker: HIT), a resource for investors and traders seeking the latest updates and insights on Health In Tech stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Health In Tech's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Health In Tech's position in the market.
Health In Tech (Nasdaq: HIT) announces its participation in the 2025 HCAA Executive Forum at the Bellagio, Las Vegas, from February 10-12, 2025. The company will showcase its Enhanced Do It Yourself Benefits System (eDIYBS), a proprietary SaaS platform for self-funded health plans.
The eDIYBS platform streamlines the quoting process for brokers, groups, and TPAs, enabling users to quote 12 plans with four tiers while customizing plan return options and selecting networks and plan designs in minutes. The platform also offers access to ManhattanLife's ancillary coverage options, including Critical Illness, Cancer Voluntary Coverage, Accident Indemnity Plus, Dental, Vision, Term Life, and GAP Coverage.
Key executives attending include Glen Hillyer (Chief Growth Officer), Del Lockett (Chief Operating Officer), and Chris Kurtenbach (Senior Vice President of Operations), who will discuss how eDIYBS can enhance health plan options and simplify self-funding for clients.
Health In Tech has announced a strategic collaboration with Vitable and MARPAI to launch a competitively priced self-funded health plan. The partnership combines Vitable's Direct Primary Care (DPC) model with MARPAI's self-funded health plans, integrated through Health In Tech's eDIYBS platform.
Vitable's enhanced primary care plan offers both in-person and virtual primary care access, mental health programs, free prescription drugs, lab work, and care navigation for households under a low monthly fee with $0 out-of-pocket costs. The collaboration aims to leverage Vitable's cost containment capabilities, which have been validated by third-party actuarial firms and reinsurance carriers.
The new offering is immediately available through Health In Tech's eDIYBS platform, targeting improved healthcare accessibility and cost reduction while maintaining high member satisfaction rates.
Health In Tech (Nasdaq: HIT), an AI-backed Insurtech platform company, has announced its participation in The Microcap Conference 2025, scheduled for January 28-30, 2025, at the Borgata Hotel Spa & Casino in Atlantic City, New Jersey. The company's management team will present their corporate strategy and hold one-on-one meetings with institutional and individual investors to discuss recent developments and growth plans.
Health In Tech (Nasdaq: HIT), an AI-powered Insurtech platform company, has announced its participation in The Microcap Conference 2025. The event will be held from January 28-30, 2025, at the Borgata Hotel Spa & Casino in Atlantic City, New Jersey. The company's management team will present their corporate strategy and conduct one-on-one meetings with institutional and individual investors to discuss recent developments and growth plans.
Health In Tech has successfully completed its Initial Public Offering (IPO), selling 2,300,000 shares of Class A common stock at $4.00 per share, raising gross proceeds of $9,200,000. The company granted the underwriter a 30-day option to purchase an additional 345,000 shares, potentially increasing total gross proceeds to $10,580,000.
The net proceeds will be utilized for system enhancements, expansion of service offerings, sales and distribution channels, talent development and retention, working capital, and general corporate purposes. American Trust Investment Services acted as the sole book-running manager for the offering, which was conducted through a Form S-1 registration statement that became effective on December 19, 2024.
Health In Tech, an Insurtech platform company, has announced the pricing of its initial public offering (IPO) of 2,300,000 shares of Class A common stock at $4.00 per share. The company will begin trading on the Nasdaq Capital Market on December 23, 2024, under the ticker symbol HIT. The underwriter has a 30-day option to purchase up to 345,000 additional shares.
The IPO is expected to close on December 24, 2024. The company plans to use the proceeds for system enhancements, service offerings expansion, sales and distribution channels growth, talent development, and working capital. American Trust Investment Services is serving as the sole book-running manager for the offering.
FAQ
What is the current stock price of Health In Tech (HIT)?
What is the market cap of Health In Tech (HIT)?
